Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis - Summary - MDSpire
Advertisement
Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis
To compare overall survival and progression-free survival of patients with PCNSL who underwent surgical resection versus those who underwent biopsy alone.
Key Findings:
Surgical resection may improve overall survival and progression-free survival in selected PCNSL patients, but evidence is mixed.
The role of surgical resection remains controversial, with studies showing both potential benefits and lack of improvement in outcomes.
High-dose methotrexate-based chemotherapy is the standard first-line treatment for PCNSL.
Interpretation:
The findings suggest that surgical resection could be beneficial for some PCNSL patients, but further research is needed to establish clear guidelines on its role.
Limitations:
Heterogeneity among included studies may affect the reliability of results, potentially leading to conflicting conclusions.
Potential publication bias and exclusion of non-English studies could limit the generalizability of the findings.
Conclusion:
The decision between surgical resection and biopsy for PCNSL should be individualized, considering potential benefits and risks for each patient.
